Search Ontology:
ChEBI

cidofovir anhydrous

Term ID
CHEBI:3696
Synonyms
  • (S)-(3-(4-amino-2-oxopyrimidin-1(2H)-yl)-1-hydroxypropan-2-yloxy)methylphosphonic acid
  • (S)-1-(3-hydroxy-2-phosphonomethoxypropyl)cytosine
  • (S)-1-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
  • (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine
  • (S)-HPMPC
  • ({[(2S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl]oxy}methyl)phosphonic acid
  • 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
  • 1-[(S)-3-hydroxy-2-(phosphonomethoxy)propyl]cytosine
  • [(S)-2-(4-Amino-2-oxo-2H-pyrimidin-1-yl)-1-hydroxymethyl-ethoxymethyl]-phosphonic acid
  • CDV
  • cidofovir
  • Cidofovir anhydrous
Definition
Cytosine substituted at the 1 position by a 3-hydroxy-2-(phosphonomethoxy)propyl group (S configuration). A nucleoside analogue, it is an injectable antiviral used for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients.
References
  • Beilstein:5080484
  • CAS:113852-37-2
  • DrugBank:DB00369
  • Drug_Central:639
  • KEGG:C06909
  • Patent:EP253412
  • Patent:US5142051
  • Wikipedia:Cidofovir
Ontology
ChEBI  ( EBI )
Resources
CTD
Relationships
is a type of
has_role
inverse has_part
inverse is_conjugate_base_of
is_conjugate_acid_of
Phenotype
Phenotype resulting from cidofovir anhydrous
Phenotype where environments contain cidofovir anhydrous
Phenotype modified by environments containing cidofovir anhydrous
Human Disease Model